Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Siofok – page 16

258 clinical trials in Siofok, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Siofok at a glance
258
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

258 trials in Siofok

Open in trial search

Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Serplulimab
  • Sponsor:Shanghai Henlius Biotech Inc.

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Hepatitis D

Not recruiting

A Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BJT-778
  • Sponsor:Mirum Pharmaceuticals Inc.

Hidradenitis

Not recruiting

A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Hyperlipidaemia

Not recruiting

A Study of Enlicitide and Rosuvastatin for Adults With High Cholesterol

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Enlicitide decanoate
  • Sponsor:Merck Sharp & Dohme LLC

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Study comparing QL2107 and pembrolizumab in patients with resected non-small cell lung cancer receiving adjuvant therapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Qilu Pharmaceutical Co. Ltd.

Embolism venous

Not recruiting

Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Rheumatoid arthritis

Not recruiting

Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:Astrazeneca AB

Dermatitis atopic

Not recruiting

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Contraception

Not recruiting

Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Levonorgestrel
  • Sponsor:Chemo Research S.L.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Siofok

What the registry says about research in the country

01 Nephrology & Cardiovascular

Innovative research focusing on chronic kidney disease (CKD) combined with hypertension management. Studies are evaluating combination therapies to potentially slow disease progression and improve patient outcomes.

  • Kidney Function Assessment
  • Blood Pressure Management
  • Disease Progression Monitoring

Research aims to enhance understanding of combined treatment approaches for complex renal conditions.

02 Respiratory & ENT

Clinical investigations targeting Eosinophilic Chronic Rhinosinusitis with nasal polyps, particularly in patients with concurrent asthma. Studies focus on innovative biological treatments for severe cases.

  • Nasal Polyp Management
  • Breathing Improvement
  • Quality of Life Assessment

Research explores targeted therapies for complex respiratory and nasal conditions.

03 Critical Care Medicine

Groundbreaking research on Acute Respiratory Distress Syndrome (ARDS) caused by pneumonia and other infections. Studies evaluate novel protein-based treatments alongside standard care protocols.

  • ARDS Treatment Innovation
  • Infection Management
  • Critical Care Outcomes

Investigation focuses on improving survival rates and treatment efficacy in severe respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.